Fund Holdings — ACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value:
$99.40M
Total Bought:
$19.52M
Total Sold:
$42.56M
Net Transaction:
-$23.04M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ocular Therapeutix, Inc.(OCUL)1,190,0711,111,071-79,000$10.35M$9.49M9.55%-$865.1K
Insmed Incorporated(INSM)107,500104,800-2,700$7.85M$7.24M7.28%-$612.1K
Tourmaline Bio Inc332,095351,842+19,747$8.54M$7.14M7.18%-$1.40M
Crinetics Pharmaceuticals In131,700122,900-8,800$6.73M$6.28M6.32%-$446.0K
Enliven Therapeutics Inc296,368267,368-29,000$7.57M$6.02M6.05%-$1.55M
Whitehawk Therapeutics, Inc.(WHWK)1,849,4021,849,4020$3.81M$5.83M5.87%+$2.03M
Praxis Precision Medicines, Inc.(PRAX)57,50067,500+10,000$3.31M$5.19M5.23%+$1.89M
Revolution Medicines, Inc.(RVMD)108,000111,700+3,700$4.90M$4.89M4.92%-$12.0K
argenx SEADR(ARGX)5,9006,910+1,010$3.20M$4.25M4.28%+$1.05M
Vaxcyte, Inc.(PCVX)135,40045,000-90,400$15.47M$3.68M3.71%-$11.79M
Trevi Therapeutics, Inc.(TRVI)290,500771,958+481,458$970.3K$3.18M3.20%+$2.21M
Ascendis Pharma A/SADR(ASND)21,00022,976+1,976$3.14M$3.16M3.18%+$27.6K
Mereo BioPharma Group plcADS(MREO)1,260,700779,308-481,392$5.18M$2.73M2.74%-$2.45M
Bright Minds Biosciences Inc.(DRUG)069,124+69,124$0$2.49M2.50%+$2.49M
Terns Pharmaceuticals Inc487,000447,500-39,500$4.06M$2.48M2.49%-$1.58M
Edgewise Therapeutics, Inc.(EWTX)63,00087,658+24,658$1.68M$2.34M2.35%+$659.0K
Helix Acquisition Corp IiCL A180,945180,9450$1.89M$1.90M1.91%+$9.1K
Unicycive Therapeutics Inc1,979,1992,303,000+323,801$807.3K$1.83M1.84%+$1.02M
Rocket Pharmaceuticals, Inc.(RCKT)190,000134,500-55,500$3.51M$1.69M1.70%-$1.82M
Liquidia Corporation(LQDA)73,500137,709+64,209$735.0K$1.62M1.63%+$884.5K
Mersana Therapeutics Inc1,200,0001,120,500-79,500$2.27M$1.60M1.61%-$665.7K
Taysha Gene Therapies, Inc.(TSHA)2,118,992884,244-1,234,748$4.26M$1.53M1.54%-$2.73M
Tectonic Therapeutic, Inc.(TECX)13,70033,008+19,308$415.1K$1.52M1.53%+$1.11M
Cidara Therapeutics Inc054,473+54,473$0$1.46M1.47%+$1.46M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
050,000+50,000$0$1.28M1.29%+$1.28M
Zymeworks Inc.(ZYME)067,240+67,240$0$984.4K0.99%+$984.4K
Eledon Pharmaceuticals, Inc.N A(ELDN)0235,750+235,750$0$971.3K0.98%+$971.3K
Verve Therapeutics Inc146,100160,200+14,100$707.1K$903.5K0.91%+$196.4K
Ultragenyx Pharmaceutical Inc.(RARE)25,10021,000-4,100$1.39M$883.5K0.89%-$510.8K
Gilead Sciences, Inc.(GILD)19,5009,150-10,350$1.63M$845.2K0.85%-$789.7K
Arcellx Inc
COMMON STOCK
62,10010,743-51,357$5.19M$823.9K0.83%-$4.36M
Sangamo Therapeutics, Inc.(SGMOQ)0740,000+740,000$0$754.8K0.76%+$754.8K
Third Harmonic Bio Inc15,50849,800+34,292$210.1K$512.4K0.52%+$302.3K
Artiva Biotherapeutics, Inc.(ARTV)44,00044,0000$679.8K$443.5K0.45%-$236.3K
Forte Biosciences Inc018,139+18,139$0$411.9K0.41%+$411.9K
Corvus Pharmaceuticals, Inc.(CRVS)074,307+74,307$0$397.5K0.40%+$397.5K
Celcuity Inc.(CELC)46,60025,000-21,600$694.8K$327.3K0.33%-$367.6K
Rapport Therapeutics, Inc.(RAPP)17,60016,400-1,200$360.4K$290.9K0.29%-$69.5K
Nuvation Bio Inc.W EXP 07 07 2027(NUVB)90,83290,8320$8.9K$20.9K0.02%+$12.0K
Acelyrin Inc364,0000-364,000$1.79M$0—-$1.79M
Benitec Biopharma Inc.(BNTC)29,8000-29,800$273.9K$0—-$273.9K
Climb Bio, Inc.(CLYM)54,0000-54,000$274.9K$0—-$274.9K
COMPASS Pathways plcADS(CMPS)386,5000-386,500$2.43M$0—-$2.43M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)18,5000-18,500$381.7K$0—-$381.7K
Dyne Therapeutics, Inc.(DYN)46,2000-46,200$1.66M$0—-$1.66M
Geron Corporation(GERN)154,9000-154,900$703.2K$0—-$703.2K
Kura Oncology, Inc.(KURA)197,0000-197,000$3.85M$0—-$3.85M
Cypherpunk Technologies Inc.(CYPH)120,5000-120,500$309.7K$0—-$309.7K
Travere Therapeutics, Inc.(TVTX)19,0000-19,000$265.8K$0—-$265.8K
Page 1 of 1
ACUTA CAPITAL PARTNERS, LLC — 13F Holdings — Q4 2024 | TickerTrail